These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12832330)

  • 1. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.
    Schram MT; Chaturvedi N; Schalkwijk C; Giorgino F; Ebeling P; Fuller JH; Stehouwer CD;
    Diabetes Care; 2003 Jul; 26(7):2165-73. PubMed ID: 12832330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.
    Schram MT; Chaturvedi N; Schalkwijk CG; Fuller JH; Stehouwer CD;
    Diabetologia; 2005 Feb; 48(2):370-8. PubMed ID: 15692810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
    Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
    Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study.
    van Bussel BC; Soedamah-Muthu SS; Henry RM; Schalkwijk CG; Ferreira I; Chaturvedi N; Toeller M; Fuller JH; Stehouwer CD;
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):758-64. PubMed ID: 22795869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.
    Klein BE; Knudtson MD; Tsai MY; Klein R
    Arch Ophthalmol; 2009 Sep; 127(9):1175-82. PubMed ID: 19752427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
    J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.
    Lopes-Virella MF; Carter RE; Gilbert GE; Klein RL; Jaffa M; Jenkins AJ; Lyons TJ; Garvey WT; Virella G;
    Diabetes Care; 2008 Oct; 31(10):2006-12. PubMed ID: 18628568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
    Ferreira I; Hovind P; Schalkwijk CG; Parving HH; Stehouwer CDA; Rossing P
    Diabetologia; 2018 Jan; 61(1):231-241. PubMed ID: 29101422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
    Baker NL; Hunt KJ; Stevens DR; Jarai G; Rosen GD; Klein RL; Virella G; Lopes-Virella MF;
    Diabetes Care; 2018 Jan; 41(1):128-135. PubMed ID: 29118060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.
    Schalkwijk CG; Poland DC; van Dijk W; Kok A; Emeis JJ; Dräger AM; Doni A; van Hinsbergh VW; Stehouwer CD
    Diabetologia; 1999 Mar; 42(3):351-7. PubMed ID: 10096789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
    Krakoff J; Funahashi T; Stehouwer CD; Schalkwijk CG; Tanaka S; Matsuzawa Y; Kobes S; Tataranni PA; Hanson RL; Knowler WC; Lindsay RS
    Diabetes Care; 2003 Jun; 26(6):1745-51. PubMed ID: 12766104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.
    Nin JW; Ferreira I; Schalkwijk CG; Prins MH; Chaturvedi N; Fuller JH; Stehouwer CD;
    Diabetologia; 2009 Apr; 52(4):705-14. PubMed ID: 19183936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
    Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus.
    Sahakyan K; Klein BE; Myers CE; Tsai MY; Klein R
    Am Heart J; 2010 Jun; 159(6):1074-80. PubMed ID: 20569722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes.
    Herder C; Fürstos JF; Nowotny B; Begun A; Strassburger K; Müssig K; Szendroedi J; Icks A; Roden M;
    Brain Behav Immun; 2017 Mar; 61():137-145. PubMed ID: 28041985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    Aburawi EH; AlKaabi J; Zoubeidi T; Shehab A; Lessan N; Al Essa A; Yasin J; Saadi H; Souid AK
    PLoS One; 2016; 11(7):e0159808. PubMed ID: 27459718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study.
    Barutta F; Bruno G; Matullo G; Chaturvedi N; Grimaldi S; Schalkwijk C; Stehouwer CD; Fuller JH; Gruden G
    Acta Diabetol; 2017 Feb; 54(2):133-139. PubMed ID: 27696070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes.
    Leinonen ES; Hiukka A; Hurt-Camejo E; Wiklund O; Sarna SS; Mattson Hultén L; Westerbacka J; Salonen RM; Salonen JT; Taskinen MR
    J Intern Med; 2004 Aug; 256(2):119-27. PubMed ID: 15257724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.